keyword
https://read.qxmd.com/read/38689359/association-between-the-neutrophil-to-lymphocyte-ratio-and-in-hospital-mortality-in-patients-with-chronic-kidney-disease-and-coronary-artery-disease-in-the-intensive-care-unit
#21
JOURNAL ARTICLE
Jingjing Luo, Yufan Zhou, Yu Song, Dashuai Wang, Meihong Li, Xinling Du, Jihong Kang, Ping Ye, Jiahong Xia
BACKGROUND: The objective of this study was to investigate the correlation between neutrophil-to-lymphocyte ratios (NLR) and the risk of in-hospital death in patients admitted to the intensive care unit (ICU) with both chronic kidney disease (CKD) and coronary artery disease (CAD). METHODS: Data from the MIMIC-IV database, which includes a vast collection of more than 50,000 ICU admissions occurring between 2008 and 2019, was utilized in the study and eICU-CRD was conducted for external verification...
April 30, 2024: European Journal of Medical Research
https://read.qxmd.com/read/38688967/combined-pretreatment-neutrophil-lymphocyte-ratio-and-platelet-lymphocyte-ratio-predicts-survival-and-prognosis-in-patients-with-non-metastatic-nasopharyngeal-carcinoma-a-retrospective-study
#22
JOURNAL ARTICLE
Dong Yang, Pian Li, Zhen Meng, Xueying Hu, Zichong Huang, Heqing Huang, Huan Dong, Yating Qin, Cong Chen, Xinghua Chen, Zhiru Li, Ziyan Zhou, Yi Li, Min Kang
The clinical significance of the combination of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) is unclear. This study investigated the predictive value of pretreatment NLR (pre-NLR) combined with pretreatment PLR (pre-PLR) for the survival and prognosis of nasopharyngeal carcinoma (NPC). A total of 765 patients with non-metastatic NPC from two hospitals were retrospectively analyzed. The pre-NLR-PLR groups were as follows: HRG, high pre-NLR and high pre-PLR. MRG, high pre-NLR and low pre-PLR or low pre-NLR and high pre-PLR...
April 30, 2024: Scientific Reports
https://read.qxmd.com/read/38688573/inflammatory-progressive-multifocal-leukoencephalopathy-with-human-t-cell-lymphotropic-virus-1-coinfection
#23
JOURNAL ARTICLE
Sachiko Hasebe, Kota Maekawa, Yukiko Shishido-Hara, Kazuo Nakamichi, Nobuaki Funata, Makio Takahashi
A middle-aged man with progressive multifocal leukoencephalopathy (PML) in a human T-cell lymphotropic virus type-1 (HTLV-1) carrier on haemodialysis presented with mild dysarthria and ataxia. Brain MRI revealed asymmetric T2 -hyperintense lesions in the cerebral white matter, cerebellum and brainstem. A small amount of JC virus (JCV) genome in cerebrospinal fluid was detected by PCR and cerebellar biopsy demonstrated JCV-DNA presence. Pathological findings showed demyelinating lesions and glial cells with mildly enlarged nuclei, accompanied by T-lymphocytes, neutrophils and plasma cell infiltration...
April 30, 2024: BMJ Case Reports
https://read.qxmd.com/read/38687817/usefulness-of-atezolizumab-plus-bevacizumab-as-second-line-therapy-for-patients-with-unresectable-hepatocellular-carcinoma
#24
JOURNAL ARTICLE
Shinpei Yamaba, Yukinori Imai, Kayoko Sugawara, Yoshihito Uchida, Akira Fuchigami, Hiroshi Uchiya, Nobuaki Nakayama, Satoshi Mochida
AIM: To clarify the efficacy of atezolizumab (ATZ) plus bevacizumab (BEV) as the second-line therapy for patients with unresectable hepatocellular carcinoma (HCC). METHODS: The subjects were 82 patients with HCC receiving ATZ/BEV, including 33 patients with previous therapies with molecular-targeted agents (MTA). Therapeutic efficacy was evaluated using contrast-enhanced CT according to the mRECIST. RESULTS: The Child-Pugh scores were 5, 6,7 and 8 in 40, 35, 5 and 2 patients, respectively, and the extents of HCC progression were BCLC stage A, B and C in 3, 31 and 48 patients, respectively...
2024: PloS One
https://read.qxmd.com/read/38686610/prognostic-value-of-preoperative-combined-neutrophil-monocyte-and-lymphocyte-scores-in-patients-with-renal-cell-carcinoma-undergoing-laparoscopic-nephrectomy-a-retrospective-study
#25
MULTICENTER STUDY
Jinliang Ni, Xiaoxiang Yao, Wei Song, Heng Zhang, Houliang Zhang, Yidi Wang, Yifan Zhang, Guangchun Wang, Keyi Wang, Weipu Mao, Bo Peng
BACKGROUND: In a multi-institutional clinical study, we assessed the prognostic significance of a novel indicator preoperative peripheral blood immune (PBIS) scores that combined ratios of preoperative lymphocyte, monocyte, and neutrophil of renal cell carcinoma (RCC) patients undergoing laparoscopic nephrectomy. METHODS: Between January 2014 and December 2019, 438 patients with RCC were retrospectively analyzed in three centers. We used X-tile software to obtain the optimum cut-off values for neutrophils, monocytes, and lymphocytes to classify the patients...
May 2024: Cancer Medicine
https://read.qxmd.com/read/38686104/predicting-amputation-rates-in-acute-limb-ischemia-is-the-neutrophil-lymphocyte-ratio-a-reliable-indicator
#26
JOURNAL ARTICLE
Mehmet Emir Erol, İsa Civelek, Sertan Ozyalcin, Deniz Sarp Beyazpınar, Ozer Kandemir
Objective This study aimed to investigate the causes of amputation and the associated biochemical parameters in patients with acute limb ischemia (ALI). Methods Patients who presented to our clinic with ALI between January 2012 and January 2022 were deemed eligible for participation. Patients who developed ALI owing to atherosclerosis or atrial fibrillation were included in the study. In contrast, patients who developed ALI owing to trauma, iatrogenic causes, or popliteal artery aneurysms were excluded...
April 2024: Curēus
https://read.qxmd.com/read/38685745/prognostic-utility-of-blood-inflammation-biomarkers-before-and-after-treatment-on-the-survival-of-patients-with-locally-advanced-non-small-cell-lung-cancer-undergoing-stereotactic-body-radiotherapy
#27
JOURNAL ARTICLE
Fang Fang, Zhen Jia, Hongliang Xie, Yangsen Cao, Xiaofei Zhu, Xiao Yu Yang, Xueling Guo, Huojun Zhang
BACKGROUND AND OBJECTIVE: The neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) were significant and succinct indicators of systemic inflammation. We assessed the influence of stereotactic body radiotherapy (SBRT) on NLR and PLR in patients with locally advanced non-small cell lung cancer (LA-NSCLC). METHODS: We reviewed the medical data of patients with LA-NSCLC who underwent SBRT between 1 January 2013 and 31 December 2018. NLR and PLR values recorded at pre- and post-SBRT were examined...
May 2024: Clinical Respiratory Journal
https://read.qxmd.com/read/38684973/association-of-inflammatory-biomarkers-with-overall-survival-in-burn-patients-a-systematic-review-and-meta-analysis
#28
JOURNAL ARTICLE
Shima Nourigheimasi, Erfan Yazdani, Arshin Ghaedi, Monireh Khanzadeh, Brandon Lucke-Wold, Emma Dioso, Aida Bazrgar, Mehrnoosh Ebadi, Shokoufeh Khanzadeh
INTRODUCTION: The inflammatory response to burn injuries can lead to organ dysfunction that ultimately results in increased mortality and morbidity. This meta-analysis was conducted to determine the efficacy of inflammatory biomarkers, including the neutrophil to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), procalcitonin (PCT), and C-reactive protein (CRP) as predictive tools of mortality among burn patients. MATERIAL AND METHODS: The biomarker levels of survivors and non-survivors were consolidated according to guidelines for Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)...
April 29, 2024: BMC Emergency Medicine
https://read.qxmd.com/read/38684839/absolute-lymphocyte-count-and-neutrophil-to-lymphocyte-ratio-as-predictors-of-cdk-4-6-inhibitor-efficacy-in-advanced-breast-cancer
#29
JOURNAL ARTICLE
Shogo Nakamoto, Tadahiko Shien, Takayuki Iwamoto, Shinichiro Kubo, Mari Yamamoto, Tetsumasa Yamashita, Chihiro Kuwahara, Masahiko Ikeda
Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i) are the standard agents for treating patients with estrogen receptor-positive and human epidermal growth factor receptor 2-negative advanced breast cancer (ER + HER2 - ABC). However, markers predicting the outcomes of CDK4/6i treatment have yet to be identified. This study was a single-center retrospective cohort study. We retrospectively evaluated 101 patients with ER + HER2 - ABC receiving CDK4/6i in combination with endocrine therapy at Fukuyama City Hospital between November 2017 and July 2021...
April 30, 2024: Scientific Reports
https://read.qxmd.com/read/38681783/protein-s-100-beta-is-increased-in-patients-with-decompensated-cirrhosis-admitted-to-icu
#30
JOURNAL ARTICLE
Nicolas Weiss, Simona Tripon, Maxime Mallet, Françoise Imbert-Bismut, Mehdi Sakka, Dominique Bonnefont-Rousselot, Philippe Sultanik, Sarah Mouri, Marika Rudler, Dominique Thabut
BACKGROUND: Hepatic encephalopathy (HE) is highly prevalent in patients with liver diseases. The pathophysiology of HE is centered on the synergic role of hyperammonemia and systemic inflammation. However, some data suggest altered functioning of the blood-brain barrier (BBB). Assessing BBB function is challenging in clinical practice and at the bedside. Protein-S-100 Beta (PS100-Beta) could be a useful peripheral marker of BBB permeability in HE. This study aimed to assess plasmatic PS100-Beta levels in a prospective cohort of patients admitted to the intensive care unit (ICU) with decompensated cirrhosis with and without overt HE...
April 2024: J Intensive Med
https://read.qxmd.com/read/38681624/the-dynamic-changes-of-peripheral-blood-cell-counts-predict-the-clinical-outcomes-of-aneurysmal-subarachnoid-hemorrhage
#31
JOURNAL ARTICLE
Yi Luo, Jian Zhao
BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is a serious type of hemorrhagic stroke. It is very important to predict the prognosis at early phase. In this work, we intend to characterize early changes in peripheral blood cells after aSAH and explore the association between peripheral blood cells and clinical outcomes after aSAH. METHODS: aSAH patients admitted between December 2019 and September 2022 were enrolled. A retrospective observational study was performed...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38680577/prognostic-role-of-platelet-to-lymphocyte-ratio-and-neutrophil-to-lymphocyte-ratio-in-patients-with-non-metastatic-and-metastatic-prostate-cancer-a-meta-analysis-and-systematic-review
#32
REVIEW
Stefano Salciccia, Marco Frisenda, Giulio Bevilacqua, Pietro Viscuso, Paolo Casale, Ettore De Berardinis, Giovanni Battista Di Pierro, Susanna Cattarino, Gloria Giorgino, Davide Rosati, Francesco Del Giudice, Alessandro Sciarra, Gianna Mariotti, Alessandro Gentilucci
OBJECTIVE: To analyze data available in the literature regarding a possible prognostic value of the platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) in prostate cancer (PCa) patients stratified in non-metastatic and metastatic diseases. METHODS: A literature search process was performed following the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines. In our meta-analysis, the pooled event rate estimated and the pooled hazard ratio were calculated using a random effect model...
April 2024: Asian Journal of Urology
https://read.qxmd.com/read/38679845/prognostic-value-of-hemogram-parameters-in-osteosarcoma-the-french-os2006-experience
#33
JOURNAL ARTICLE
Paul Bastard, Nathalie Cozic, Régis Brion, Nathalie Gaspar, Sophie Piperno-Neumann, Camille Cordero, Estelle Leculée-Thébaud, Anne Gomez-Mascard, Françoise Rédini, Antonin Marchais, Raina Ikonomova, Morgane Cleirec, Valérie Laurence, Charlotte Rigaud, Rachid Abbas, Franck Verrecchia, Laurence Brugières, Véronique Minard-Colin
BACKGROUND: Previous studies have shown that neutrophil-to-lymphocyte (NLR) ratio at diagnosis and early lymphocytes recovery on doxorubicin-based chemotherapy, may impact the outcome in patients with osteosarcoma (OST). This study aimed to evaluate the prognostic value of hemogram parameters in patients with OST treated with high-dose methotrexate and etoposide/ifosfamide (M-EI) chemotherapy. MATERIALS AND METHODS: We retrospectively analyzed the prognostic value of various hemogram parameters at diagnosis and during therapy in a large consecutive cohort of patients with OST included in the French OS2006 trial and treated with M-EI chemotherapy...
April 28, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38679384/role-of-inflammatory-markers-in-the-assessment-of-meningitis-in-adult-patients-with-fever-and-headache
#34
JOURNAL ARTICLE
Toshihiko Takada, Kenji Yoshida, Sugihiro Hamaguchi, Shunichi Fukuhara
BACKGROUND: Meningitis, especially of bacterial origin, is a medical emergency that must be diagnosed promptly. However, due to the associated risks of complications of lumbar puncture, it is crucial to identify individuals who truly need it. The aim of this study was to assess the diagnostic role of inflammatory markers in distinguishing among patients without meningitis, those with aseptic meningitis, and those with bacterial meningitis. METHODS: This was a retrospective, diagnostic study at an acute care hospital, involving adult patients who presented to either ambulatory care or the emergency department with fever and headache, but without altered mental status or neurological deficits...
April 26, 2024: Journal of Infection and Chemotherapy: Official Journal of the Japan Society of Chemotherapy
https://read.qxmd.com/read/38677767/sarcopenic-obesity-promotes-recurrence-in-patients-undergoing-resection-for-colorectal-liver-metastases-crlm
#35
JOURNAL ARTICLE
Doris Wagner, Robert Karitnig, Valerie Wienerroither, Hans Michael Hau, Andri Lederer, Robert Sucher, Peter Kornprat
BACKGROUND/AIM: Sarcopenia, is predictive of a worse outcome after resection for colorectal liver metastases (CRLM). Obesity leads to a metabolic double burden if sarcopenia is as present, prompting malignancy progression, known as sarcopenic obesity (SO). This study aimed to compare sarcopenia and SO in patients undergoing CRLM resection, to prognostic parameters. PATIENTS AND METHODS: The skeletal muscle index (SMI) defined sarcopenia using sex specific cut off values (48...
May 2024: Anticancer Research
https://read.qxmd.com/read/38677749/predicting-trabectedin-efficacy-in-soft-tissue-sarcoma-inflammatory-biomarker-analysis
#36
JOURNAL ARTICLE
Toru Imai, Yuki Kojima, Tatsunori Shimoi, Hisaki Aiba, Hitomi S Okuma, Ayumi Saito, Shosuke Kita, Kasumi Yamamoto, Aiko Maejima, Tadaaki Nishikawa, Kazuki Sudo, Emi Noguchi, Akihiko Yoshida, Yoshiyuki Matsui, Shintaro Iwata, Eisuke Kobayashi, Akira Kawai, Ryoko Udagawa, Yasuhiro Fujiwara, Kan Yonemori
BACKGROUND/AIM: Trabectedin is used as a treatment for advanced-stage soft tissue sarcomas (STSs), particularly liposarcoma and leiomyosarcoma. Aside from its direct effect on tumor cells, trabectedin can affect the immune system in the tumor microenvironment. This study aimed to evaluate whether inflammatory biomarkers predict trabectedin efficacy in STSs. PATIENTS AND METHODS: We retrospectively reviewed the clinical features and outcomes of patients with STS treated with trabectedin at our institution between 2016 and 2020...
May 2024: Anticancer Research
https://read.qxmd.com/read/38676847/periprocedural-changes-of-serum-biomarkers-in-predicting-complications-following-bariatric-surgery-for-obesity-systematic-review-and-meta-analysis
#37
REVIEW
Hani AziziKia, Shayan Shojaei, Asma Mousavi, Dorsa Salabat, Farhad Shaker, Reza Hosseini Dolama, Hanieh Radkhah, Sanam Alilou
Bariatric surgery is an effective treatment for severe obesity, but complications and peri-operative monitoring are important considerations. We conducted a comprehensive review of studies assessing pre-operative biomarkers and complications in patients undergoing bariatric surgery. A total of 14 studies were included. Gastric leak, infections, bleeding, obstruction or stenosis, hypoglycemia, and hypoalbuminemia were the most common complications observed. Our analysis showed a significant association between lower pre-operative albumin levels and complications (SMD [95%CI] =  - 0...
April 27, 2024: Obesity Surgery
https://read.qxmd.com/read/38676683/-long-term-efficacy-and-safety-of-divozilimab-during-2-year-treatment-of-multiple-sclerosis-patients-in-randomized-double-blind-placebo-controlled-clinical-trial-bcd-132-4-mirantibus
#38
RANDOMIZED CONTROLLED TRIAL
A N Boyko, V M Alifirova, I G Lukashevich, Z A Goncharova, I V Greshnova, L G Zaslavsky, S V Kotov, N A Malkova, G N Mishin, E V Parshina, I Ye Poverennova, L N Prakhova, S A Sivertseva, I V Smagina, N A Totolyan, Yu V Trinitatsky, T N Trushnikova, F A Khabirov, J Yu Chefranova, S G Shchur, V A Dudin, D V Pokhabov, A V Artemeva, A V Eremeeva, Yu N Linkova, A V Zinkina-Orikhan
OBJECTIVE: To evaluate the efficacy and safety of the anti-CD20 monoclonal antibody divozilimab (DIV) used as an intravenous infusion at a dose of 500 mg every 24 weeks during 100 weeks for the treatment of patients with multiple sclerosis (MS), including relapsing-remitting multiple sclerosis (RRMS) and secondary progressive MS (SPMS) with relapses. MATERIAL AND METHODS: The multicenter, randomized, double-blind and double-masked phase III clinical trial (CT) BCD-132-4/MIRANTIBUS (NCT05385744) included 338 adult patients with MS distributed in a 1:1 ratio into two groups: DIV 500 mg and teriflunomide (TRF) 14 mg...
2024: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38676479/nomogram-to-predict-90-day-all-cause-mortality-in-acute-ischemic-stroke-patients-after-endovascular-thrombectomy
#39
JOURNAL ARTICLE
Shiya Zhang, Shuai Yu, Xiaocui Wang, Zhiliang Guo, Jie Hou, Huaishun Wang, Zhichao Huang, Guodong Xiao, Shoujiang You
OBJECTIVE: Although Endovascular Thrombectomy (EVT) significantly improves the prognosis of Acute Ischemic Stroke (AIS) patients with large vessel occlusion, the mortality rate remains higher. This study aimed to construct and validate a nomogram for predicting 90-day all-cause mortality in AIS patients with large vessel occlusion and who have undergone EVT. METHODS: AIS patients with large vessel occlusion in the anterior circulation who underwent EVT from May 2017 to December 2022 were included...
April 25, 2024: Current Neurovascular Research
https://read.qxmd.com/read/38675423/potential-anti-inflammatory-and-anti-fatigue-effects-of-an-oral-food-supplement-in-long-covid-patients
#40
JOURNAL ARTICLE
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Chiara Vita, Giulia Montalto, Gloria Giorgino, Carlo Chiaramonte, Cartesio D'Agostini, Sergio Bernardini, Massimo Pieri
Long coronavirus disease (COVID) syndrome leads to chronic inflammatory state onset that can have a multisystem impact and compromise organ function. Moreover, long COVID syndrome is often characterized by the presence of chronic fatigue, which affects subjects' daily activities and worsens their quality of life. The aim of our double-blind, placebo-controlled randomized trial (protocol code RS 150.21, approved on 4 November 2021) was to evaluate the beneficial effects of the consumption of 2 cps/day, for two months, of an oral food supplement (OFS), based on Echinacea angustifolia , rosehip, propolis, royal jelly and zinc, in long COVID patients, compared to a two-month placebo period...
April 5, 2024: Pharmaceuticals
keyword
keyword
38377
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.